Categories
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
661
Antibiotics
247
Bioactive Small Molecules
714
Aroma Chemicals
203
Biochemicals
998
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
52
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
254
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
323
Ion-Pair Reagents
24
Ligands
79
Organics
1288
Oxazoles
3
Peptide Reagents
90
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
43
Reagents
96
Research Organics & Inorganics
747
Salts
282
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
290
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
91
Water Analysis
11
Celecoxib
(70641057 | 169590-42-5)
CAS: | 169590-42-5 |
---|---|
Molecular Formula: | C17H14F3N3O2S |
Molecular Weight: | 381.37 |
Availablility: | In Stock |
---|---|
Downloads: | | |
This product is subject to a hazardous surcharge. The exact amount will be confirmed by our sales team.
70641057-25mg | 25mg | £143.90 | |
Bulk Order |
70641057-25mg | 25mg | €201.50 | |
Bulk Order |
70641057-25mg | 25mg | $215.90 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 70641057 | ||||
Product Name | Celecoxib | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 169590-42-5 | ||||
Molecular Formula | C17H14F3N3O2S | ||||
Molecular Weight | 381.37 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 2935909099 |
Product Specification
Assay/Purity | 98.0%-102.0% | ||||
Melting Point | 160℃-164℃ | ||||
Water | ≤0.5% | ||||
Total impurity | ≤0.5% | ||||
Heavy metals | ≤20ppm | ||||
Residue on Ignition | ≤0.2% | ||||
Appearance | White or almost white crystalline powder |
Safety Information
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|